Literature DB >> 21480360

"Real-Life" comparison of pegylated-interferon 2a versus 2b combination therapy of chronic hepatitis C virus.

Julian Schulze Zur Wiesch, Neele Pudelski, Lena Hoepner, Michael Supplieth, Peter Buggisch, Ansgar W Lohse, Stefan Lüth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21480360     DOI： 10.1002/hep.24185

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  2 in total

1.  German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients.

Authors:  Jan van Lunzen; Julian Schulze Zur Wiesch; Claudia Beisel; Martin Heuer; Benjamin Otto; Johannes Jochum; Stefan Schmiedel; Sandra Hertling; Olaf Degen; Stefan Lüth
Journal:  AIDS Res Ther       Date:  2014-07-01       Impact factor: 2.250

2.  Safety and efficacy of protease inhibitor based combination therapy in a single-center "real-life" cohort of 110 patients with chronic hepatitis C genotype 1 infection.

Authors:  Malte H Wehmeyer; Friederike Eißing; Sabine Jordan; Claudia Röder; Annette Hennigs; Olaf Degen; Anja Hüfner; Sandra Hertling; Stefan Schmiedel; Martina Sterneck; Jan van Lunzen; Ansgar W Lohse; Julian Schulze zur Wiesch; Stefan Lüth
Journal:  BMC Gastroenterol       Date:  2014-05-05       Impact factor: 3.067
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.